Mark Drazner

Mark Drazner, M.D., M.Sc., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a leading expert in the Division of Cardiology. He currently serves as the Vice Chair of Clinical Affairs for Internal Medicine and holds the James M. Wooten Chair in Cardiology. Dr. Drazner specializes in cardiomyopathy and advanced heart failure, including heart transplants and ventricular assist devices.

• Medical degree: Washington University in St. Louis
• Internal Medicine Residency: UT Southwestern Medical Center (Chief Resident)
• Cardiology Fellowship: Duke University
• Heart Failure Fellowship: Brigham and Women’s Hospital
• Master's in Epidemiology: Harvard University School of Public Health

Dr. Drazner’s research focuses on heart failure, particularly advanced heart failure and transplantation, left ventricular hypertrophy, and telehealth applications in cardiology. He has contributed to clinical guidelines and studies on SGLT2 inhibitors, congestion management, and the universal definition of heart failure. His work bridges clinical practice, epidemiological analysis, and technological innovation.

The 15 most recent publications highlight expertise in heart failure classification (2021), telehealth (2020-2021), SGLT2 inhibitors (2021), ventricular assist devices (2012), and epidemiological trends (2005-2011). Topics include reverse remodeling, filling pressures, and the ethical implications of patient advocacy in transplant decisions.

• Patricia and William L. Watson Jr. M.D. Award (2020)
• Laennec Master Clinician Award (AHA, Council of Clinical Cardiology)
• Texas Super Doctor (2009-2021)

Dr. Drazner is a Diplomate of the American Board of Internal Medicine in advanced heart failure and transplant cardiology. He is affiliated with the American Heart Association, American College of Cardiology, Heart Failure Society of America (President), and International Society for Heart and Lung Transplantation.